|
|
The epidemiologically expected benefits of BP lowering for stroke risk reduction are broadly consistent across a range of different population subgroups. There are greater benefits from larger BP: reduction, and initiating and maintaining BP reduction for stroke prevention is a more important issue than choice of initial agent. |
|